Pathophysiology of the irritable bowel syndrome - Reflections of today

被引:24
作者
Hellstrom, Per M. [1 ]
机构
[1] Uppsala Univ, Dept Med Sci, Gastroenterol Unit, Bldg 40,5th Floor, SE-75185 Uppsala, Sweden
基金
瑞典研究理事会;
关键词
Dysbiosis; Irritable bowel syndrome; Motility; Rectal distension; Serotonin; CORTICOTROPIN-RELEASING HORMONE; RECEPTOR ANTAGONIST; ABDOMINAL-PAIN; PERCEPTION; ACTIVATION; TRANSPORTER; MICROBIOTA; DISORDERS; SYSTEM; CELLS;
D O I
10.1016/j.bpg.2019.05.007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Irritable bowel syndrome (IBS) is a chronic gastrointestinal symptom complex defined by abdominal pain and disturbed bowel habits over 3 months within a period of 6 months, in absence of any identifiable organic pathology. Over the years, speculations of the pathophysiology of IBS has moved from elusive central nervous symptoms impinging on psychosomatic disease, to objective signs of intestinal fermentation with abdominal bloating and intestinal dysmotility. The specific subgroup of post infectious IBS is of special interest since it opens the possibility of dysbiosis as the pivotal point for development of IBS in association with traveler's diarrhea or antibiotic treatment with ensuing dysbiosis and abdominal symptoms that may resolve over decades. The undefined disease mechanisms that take place within the gut seem responsible for the gut-brain signaling leading to activation of brain centers that drive the clinical picture of IBS, further modulated by the patient's social background and previous lifetime events. (C) 2019 Published by Elsevier Ltd.
引用
收藏
页数:6
相关论文
共 44 条
  • [1] Mechanisms of hypersensitivity in IBS and functional disorders
    Azpiroz, F.
    Bouin, M.
    Camilleri, M.
    Mayer, E. A.
    Poitras, P.
    Serra, J.
    Spiller, R. C.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 : 62 - 88
  • [2] Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
    Barbara, G
    Stanghellini, V
    De Giorgio, R
    Cremon, C
    Cottrell, GS
    Santini, D
    Pasquinelli, G
    Morselli-Labate, AM
    Grady, EF
    Bunnett, NW
    Collins, SM
    Corinalidesi, R
    [J]. GASTROENTEROLOGY, 2004, 126 (03) : 693 - 702
  • [3] Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron
    Berman, SM
    Chang, L
    Suyenobu, B
    Derbyshire, SW
    Stains, J
    Fitzgerald, L
    Mandelkern, M
    Hamm, L
    Vogt, B
    Naliboff, BD
    Mayer, EA
    [J]. GASTROENTEROLOGY, 2002, 123 (04) : 969 - 977
  • [4] Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls
    Böhmelt, AH
    Nater, UM
    Franke, S
    Hellhammer, DH
    Ehlert, U
    [J]. PSYCHOSOMATIC MEDICINE, 2005, 67 (02): : 288 - 294
  • [5] Rectal distention testing in patients with irritable bowel syndrome:: Sensitivity, specificity, and predictive values of pain sensory thresholds
    Bouin, M
    Plourde, V
    Boivin, M
    Riberdy, M
    Lupien, F
    Laganière, M
    Verrier, P
    Poitras, P
    [J]. GASTROENTEROLOGY, 2002, 122 (07) : 1771 - 1777
  • [6] Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome
    Camilleri, M
    Atanasova, E
    Carlson, PJ
    Ahmad, U
    Kim, HJ
    Viramontes, BE
    McKinzie, S
    Urrutia, R
    [J]. GASTROENTEROLOGY, 2002, 123 (02) : 425 - 432
  • [7] Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome
    Camilleri, Michael
    Mckinzie, Sanna
    Busciglio, Irene
    Low, Phillip A.
    Sweetser, Seth
    Burtow, Duane
    Baxter, Kari
    Ryks, Michael
    Zinsmeister, Alan R.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (07) : 772 - 781
  • [8] Activation of the mucosal immune system in irritable bowel syndrome
    Chadwick, VS
    Chen, WX
    Shu, DR
    Paulus, B
    Bethwaite, P
    Tie, A
    Wilson, I
    [J]. GASTROENTEROLOGY, 2002, 122 (07) : 1778 - 1783
  • [9] Gender differences in irritable bowel syndrome
    Chang, L
    Heitkemper, MM
    [J]. GASTROENTEROLOGY, 2002, 123 (05) : 1686 - 1701
  • [10] Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome
    Coates, MD
    Mahoney, CR
    Linden, DR
    Sampson, JE
    Chen, J
    Blaszyk, H
    Crowell, MD
    Sharkey, KA
    Gershon, MD
    Mawe, GM
    Moses, PL
    [J]. GASTROENTEROLOGY, 2004, 126 (07) : 1657 - 1664